Related Experiment Video
Updated: Jul 27, 2026

Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs
Published on: April 17, 2021
Medical management after myocardial infarction: an evidence-based perspective
1Department of Medicine, University of Auckland School of Medicine, New Zealand.
Insights
Effective myocardial infarction (MI) therapies require careful patient assessment. Post-MI treatment focuses on minimizing delay, long-term aspirin, and risk factor modification for optimal recovery.
Area of Science:
- Cardiology
- Internal Medicine
- Pharmacology
Background:
- Myocardial infarction (MI) necessitates comprehensive post-event management.
- Individualized treatment strategies are crucial for maximizing patient benefit after MI.
Purpose of the Study:
- To outline effective therapies for patients following myocardial infarction (MI).
- To emphasize the importance of patient assessment and individualized treatment plans.
Main Methods:
- Assessment of continuing myocardial ischemia and left ventricular (LV) function.
- Review of patient risk factors and circumstances pertinent to rehabilitation.
- Consideration of thrombolysis, aspirin, beta-blockers, ACE inhibitors, nitrates, and anticoagulants.
Main Results:
- Thrombolysis and acute aspirin offer proven benefits, with prompt administration being critical.
- Long-term aspirin is indicated for all patients.
- Beta-blockers, ACE inhibitors, and nitrates show benefit, though optimal timing and combinations require further study.
Conclusions:
- Post-MI care requires a multifaceted approach including immediate interventions and long-term management.
- Risk factor modification, including smoking cessation and cholesterol reduction, is integral to rehabilitation.
- Patient education and counseling are vital components of care initiated during hospitalization and continued post-discharge.
Abstract:
There are a number of effective therapies to consider for the patient after myocardial infarction (MI). Careful patient assessment and individualisation of treatment is required for maximum benefit. Key aspects of assessment include consideration of continuing myocardial ischaemia, evaluation of LV function, review of risk factors and patient circumstances relevant to rehabilitation. Thrombolysis for eligible patients and acute aspirin are of proven benefit and the priority is to minimise delay in treatment. Aspirin is indicated long term for all patients. Beta-blockers, ACE inhibitors and possibly nitrates are also beneficial, but questions remain about optimal timing and combination treatment. Anticoagulants should be considered in selected, high-risk patients. Education-counselling measures should be initiated in hospital and continued with risk-factor modification as part of rehabilitation after discharge. Priority should be given to smoking cessation where applicable, and to reduction of elevated serum cholesterol levels.
More Related Videos
05:41Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control
Published on: December 16, 2022
07:40Protection of H9c2 Myocardial Cells from Oxidative Stress by Crocetin via PINK1/Parkin Pathway-Mediated Mitophagy
Published on: May 26, 2023
Related Concept Videos
Myocarditis III: Medical Management
Myocarditis IV: Nursing Management
Acute Coronary Syndrome IV: Interprofessional Care
Angina IV: Management
Angina V: Nursing Management
Cardiomyopathy V: Interprofessional Care